Historical record - last NADAC effective date: 2/1/2022
Product Information
CAMBIA 50 MG POWDER PACKET is a brand product labeled by Assertio Therapeutics, Inc., priced at $94.4349 per EA under NDC 13913001203. Its NADAC has been published 303 times since Dec 14, 2016.
FDA first approved this application on Jun 17, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the diclofenac potassium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/1
Manufacturer
Assertio Therapeutics, Inc.NDC
13913001203
Classification
Brand
Dosage Form
POWDER, FOR SOLUTION
Route
ORAL
Effective Date
2/1/2022
Active Ingredients
DICLOFENAC POTASSIUMApproval Type
New Drug (NDA)
FDA Application
NDA022165FDA Approved
6/17/2009
TE Code
AB
On Market Since
3/10/2016
Pharmacological Classes
Price Statistics
The NADAC for CAMBIA 50 MG POWDER PACKET has been published 303 times since Dec 14, 2016, and over the history we have for it it has risen 88.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $94.4349 per EA |
|---|---|
| All-time high | $94.4349 (Sep 28, 2022) |
| All-time low | $49.9933 (Dec 14, 2016) |
| Median price | $72.2405 |
| Average price | $73.8482 |
| Largest weekly change | +9.9% (Feb 22, 2017) |
| Weeks tracked | 303 |
| Tracking since | Dec 14, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
+8.0%
All
+88.9%
Last surveyed Sep 28, 2022 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the diclofenac potassium market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CAMBIA 50 MG POWDER PACKET?
The current National Average Drug Acquisition Cost (NADAC) for CAMBIA 50 MG POWDER PACKET, manufactured by Assertio Therapeutics, Inc., is $94.4349 per EA (NDC 13913001203), effective Sep 28, 2022.
How has the price of CAMBIA 50 MG POWDER PACKET changed over time?
Over the history we have for it, the NADAC for CAMBIA 50 MG POWDER PACKET has risen 88.9%. It has been tracked across 303 weekly CMS publications since Dec 14, 2016.
What are the highest and lowest recorded NADAC prices for CAMBIA 50 MG POWDER PACKET?
Since Dec 14, 2016, the NADAC for CAMBIA 50 MG POWDER PACKET has ranged from a low of $49.9933 (Dec 14, 2016) to a high of $94.4349 (Sep 28, 2022), with a median of $72.2405 per EA.
Are there cheaper alternatives to CAMBIA 50 MG POWDER PACKET?
No other NADAC-published product currently shares the active ingredient and strength of CAMBIA 50 MG POWDER PACKET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CAMBIA 50 MG POWDER PACKET?
CAMBIA 50 MG POWDER PACKET (NDC 13913001203) is labeled by Assertio Therapeutics, Inc., and CMS classifies it as a brand product.